Chunchao Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chunchao Jiang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Lin Zhang
Department of Plastic Surgery and Burns, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University), China
1 shared publication - Wenfu Luo
Department of Plastic Surgery and Burns, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University), China
1 shared publication - Xianan Zhang
Department of Plastic Surgery and Burns, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University), China
1 shared publication - Xizhi Yang
Department of Plastic Surgery and Burns, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University), China
1 shared publication - Yan Liu
Department of Plastic Surgery and Burns, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University), China
1 shared publication Yunzhi Ai
Department of Plastic Surgery and Burns, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University), China
1 shared publication
Latest Publications
- Open Access
- 18 December 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 1907-1912
Diagnosis, treatment management, and challenges in neurofibromatosis type 1: a case report with mixed features
Introduction: Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder; however, the incidence of plexiform neurofibromas remains relatively low. This article presents a case of mixed-type NF1 with plexiform neurofibroma. Case Presentation: Following domestic and international expert consensus, a multidisciplinary team conducted a comprehensive evaluation and formulated an individualized treatment plan. Although the diagnosis of NF1 was confirmed, the precise origin of the massive superficial mass in the child remains uncertain. Clinical Discussion: This study provides a comprehensive exploration of the clinical manifestations and theoretical underpinnings that facilitate the precise diagnosis, treatment, and long-term management of patients with NF1. Conclusion: In conclusion, the clinical management of pediatric NF1 patients is complex as therapeutic interventions are not for all. Due to heterogeneous manifestations and variable disease trajectories, there is no standardized treatment algorithm. Integrating molecular diagnostics, targeted therapies, and multidisciplinary care is crucial for personalized and effective long – term management of those with this genetic disorder.
- 18 December 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 1907-1912
Open AccessDiagnosis, treatment management, and challenges in neurofibromatosis type 1: a case report with mixed features
Introduction: Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder; however, the incidence of plexiform neurofibromas remains relatively low. This article presents a case of mixed-type NF1 with plexiform neurofibroma. Case Presentation: Following domestic and international expert consensus, a multidisciplinary team conducted a comprehensive evaluation and formulated an individualized treatment plan. Although the diagnosis of NF1 was confirmed, the precise origin of the massive superficial mass in the child remains uncertain. Clinical Discussion: This study provides a comprehensive exploration of the clinical manifestations and theoretical underpinnings that facilitate the precise diagnosis, treatment, and long-term management of patients with NF1. Conclusion: In conclusion, the clinical management of pediatric NF1 patients is complex as therapeutic interventions are not for all. Due to heterogeneous manifestations and variable disease trajectories, there is no standardized treatment algorithm. Integrating molecular diagnostics, targeted therapies, and multidisciplinary care is crucial for personalized and effective long – term management of those with this genetic disorder.